Psychemedics Corporation PMD
2.67
0.00
0.00%
as of 2 Mar
- Market cap
- $15.7M
- P/E
- 0.0×
Follow PMD
| Dec '24 | Sep '24 | Jun '24 | Mar '24 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.67 | 0.67 | 0.66 | 0.76 | |
P/FCF ratio |
16.33 | 32.65 | 0.00 | 0.00 | |
P/Operating CF |
12.90 | 51.77 | 113.92 | (34.49) | |
P/B ratio |
2.56 | 2.50 | 2.38 | 2.60 | |
Price to Tangible BV |
2.56 | 2.50 | 2.38 | 2.60 | |
EV/Sales |
0.61 | 0.62 | 0.60 | 0.70 | |
EV/EBITDA |
63.87 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
12.93 | 21.86 | (19.33) | (8.80) | |
EV/FCF |
14.92 | 29.98 | (14.83) | (7.89) | |
Quick Ratio |
1.45 | 1.25 | 1.20 | 1.27 | |
Current Ratio |
1.82 | 1.59 | 1.60 | 1.48 | |
Net Debt/EBITDA |
(2.35) | 9.46 | 6.10 | 74.44 | |
Debt/Assets |
0.64% | 0.62% | 0.00% | 2.06% | |
Debt/Equity |
0.01 | 0.01 | 0.00 | 0.04 | |
Asset Turnover |
1.91 | 1.69 | 1.57 | 1.49 | |
Operating CF/Net income |
5.39 | (0.49) | (0.15) | 0.69 | |
Capex/Depreciation |
(0.14) | (0.03) | (0.06) | (0.01) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
4.05% | 3.32% | 4.00% | 3.90% | |
Selling, General and Administrative Expense of Revenue |
23.53% | 47.57% | 47.84% | 46.29% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
2.10% | 4.64% | 6.07% | 5.54% | |
Graham Net Nets |
0.13 | 0.12 | 0.12 | 0.08 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(14.29%) | (22.08%) | (33.19%) | (27.40%) | |
Free Cash Flow Yield |
6.13% | 3.06% | (6.19%) | (11.81%) | |
Revenue per Share |
0.75 | 0.88 | 0.81 | 0.92 | |
Operating CF per Share |
0.17 | 0.04 | 0.02 | (0.08) | |
Capex per Share |
(0.01) | 0.00 | (0.01) | 0.00 | |
Free Cash Flow per Share |
0.16 | 0.04 | 0.01 | (0.08) | |
Cash per Share |
0.24 | 0.24 | 0.25 | 0.24 | |
Shareholders Equity per Share |
0.87 | 0.92 | 0.99 | 1.08 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.87 | 0.92 | 0.99 | 1.08 | |
Free Cash Flow |
0.96 | 0.25 | 0.08 | (0.48) | |
Working Capital |
2.23 | 2.25 | 2.26 | 2.00 | |
Capital Expenditures |
(0.06) | (0.01) | (0.04) | (0.01) | |
Net Current Asset Value |
1.75 | 1.66 | 1.64 | 1.32 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.00 | 0.01 | 0.00 | |
Net Profit Margin |
4.27% | (10.34%) | (17.49%) | (12.84%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
3.11 | 4.16 | 3.54 | 3.98 | |
Average Payables |
0.61 | 0.91 | 0.73 | 0.96 | |
Average Assets |
10.32 | 11.97 | 13.25 | 14.53 | |
Average Common Equity |
5.90 | 6.44 | 7.43 | 8.22 |
Columns are period end dates